Clinical Trial Update: Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency [Phase 3]

View source ↗

Summary

A Phase 3 trial of Liprotamase in cystic fibrosis-related exocrine pancreatic insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Liprotamase (liprotamase)

Snippet

Sponsor: Anthera Pharmaceuticals | Conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency | Phase 3 | Status: COMPLETED